Back to search

Article

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening

2021-07-05

Abstract excerpt

Drug development for specific antiviral agents against coronavirus disease 2019 (COVID-19) is still an unmet medical need as the pandemic continues to spread globally. Although huge efforts for drug repurposing and compound screens have put forth, only few compounds remain in late stage clinical trials. New approaches and assays are needed to accelerate COVID-19 drug discovery and development. Here we report a tim...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f495b01b-9e2b-504f-a080-f0d435ccc418
DOI
10.1101/2021.07.03.450938
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screeningDOI 10.1101/2021.07.03.450938
Select a neighboring publication to make it the new centre.